Cooper : Submission of Matters to a Vote of Security Holders - Form 8-K
March 22, 2024 at 06:04 am EDT
Share
ITEM 5.07. Submission of Matters to a Vote of Security Holders.
On March 19, 2024, The Cooper Companies, Inc. ("Cooper") held its Annual Meeting of Stockholders. The matters listed below were submitted to a vote of the stockholders through the solicitation of proxies, and the proposals are described in detail in Cooper's definitive Proxy Statement filed with the Securities and Exchange Commission ("SEC") on February 2, 2024. Votes were cast by the stockholders as set forth below.
Proposal 1 - Election of Directors
The following individuals were elected to serve as directors of Cooper until the 2025 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.
Nominee
For
Against
Broker Non-Votes
Colleen E. Jay
43,007,549
1,418,159
1,275,869
William A. Kozy
41,922,289
2,503,419
1,275,869
Lawrence E. Kurzius
40,479,136
3,946,572
1,275,869
Cynthia L. Lucchese
43,915,382
510,326
1,275,869
Teresa S. Madden
43,746,369
679,339
1,275,869
Maria Rivas, M.D.
43,910,777
514,931
1,275,869
Robert S. Weiss
41,549,561
2,876,147
1,275,869
Albert G. White III
44,225,910
199,798
1,275,869
Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm
The appointment of KPMG LLP to serve as Cooper's independent registered public accounting firm for the fiscal year ending October 31, 2024 was ratified.
For
Against
Abstain
Broker Non-Vote
41,225,096
3,660,265
816,216
-
Proposal 3 - Advisory Vote on Executive Compensation
The stockholders adopted, on an advisory basis, a resolution approving the compensation of Cooper's Named Executive Officers as presented in the Proxy Statement.
For
Against
Abstain
Broker Non-Vote
40,001,914
4,406,987
16,807
1,275,869
Attachments
Original Link
Permalink
Disclaimer
The Cooper Companies Inc. published this content on
22 March 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
22 March 2024 10:03:22 UTC.
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.